e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Edwards Lifesciences
(NY:
EW
)
82.67
+0.98 (+1.20%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 25, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,639,574
Open
82.44
Bid (Size)
81.07 (100)
Ask (Size)
83.90 (300)
Prev. Close
81.69
Today's Range
81.28 - 83.09
52wk Range
65.94 - 87.89
Shares Outstanding
580,800,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares
↗
March 15, 2026
This biotech firm develops therapies targeting cystic fibrosis, with shares up nearly 90% year-over-year as of the latest filing.
Via
The Motley Fool
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share
↗
March 15, 2026
RAPT Therapeutics develops oral therapies for cancer and inflammation, with key drug candidates currently in clinical trials.
Via
The Motley Fool
Performance
YTD
-3.1%
-3.1%
1 Month
+0.3%
+0.3%
3 Month
-4.2%
-4.2%
6 Month
+10.7%
+10.7%
1 Year
+16.0%
+16.0%
More News
Read More
Friday's session: top gainers and losers in the S&P500 index
↗
March 13, 2026
Via
Chartmill
Edwards Lifesciences Corp (NYSE:EW) Reports Mixed Q4 Results, Misses EPS Estimates
↗
February 10, 2026
Via
Chartmill
Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose
February 26, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing
↗
February 20, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape
February 19, 2026
Via
MarketMinute
Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences
February 19, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Exploring the top movers within the S&P500 index during today's session.
↗
February 17, 2026
Via
Chartmill
The Return of the Mega-Deal: How 2026’s Regulatory Pragmatism is Reshaping Corporate America
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day
February 13, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH
↗
February 12, 2026
Via
MarketBeat
Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights
February 12, 2026
From
Halper Sadeh LLC
Via
GlobeNewswire
Unusual volume S&P500 stocks in Wednesday's session
↗
February 11, 2026
Via
Chartmill
Edwards Lifesciences (EW) Earnings Transcript
↗
February 10, 2026
Via
The Motley Fool
Edwards Lifesciences Reports Fourth Quarter Results
February 10, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition
February 05, 2026
Via
MarketMinute
Topics
Supply Chain
Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
February 03, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference
February 02, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
The $14.5 Billion Clot-Bust: Boston Scientific’s Bold Bet on Penumbra Signals a New Era of Medtech Giants
January 27, 2026
Via
MarketMinute
Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors
↗
January 25, 2026
Via
MarketBeat
The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare
January 23, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
The Death of the Quick Deal: One Year Under the New FTC and DOJ Merger Regime
January 23, 2026
Via
MarketMinute
Topics
Economy
AI Diagnostics: The End of the High-Cost Imaging Era
January 16, 2026
From
Equity Insider
Via
GlobeNewswire
The Thrombectomy Titan: Boston Scientific Shakes MedTech with $14.5 Billion Penumbra Acquisition
January 15, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Frequently Asked Questions
Is Edwards Lifesciences publicly traded?
Yes, Edwards Lifesciences is publicly traded.
What exchange does Edwards Lifesciences trade on?
Edwards Lifesciences trades on the New York Stock Exchange
What is the ticker symbol for Edwards Lifesciences?
The ticker symbol for Edwards Lifesciences is EW on the New York Stock Exchange
What is the current price of Edwards Lifesciences?
The current price of Edwards Lifesciences is 82.67
When was Edwards Lifesciences last traded?
The last trade of Edwards Lifesciences was at 03/25/26 07:00 PM ET
What is the market capitalization of Edwards Lifesciences?
The market capitalization of Edwards Lifesciences is 48.01B
How many shares of Edwards Lifesciences are outstanding?
Edwards Lifesciences has 48B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert